Brian Karvelas, MD in San Jose, CA - Pain Medicine

Brian Karvelas, MD is a Pain Medicine - Pain Medicine physician based in San Jose, California. Brian Karvelas is licensed to practice in California (license number A063301) and his current practice location is 902 Newhall St, San Jose, California. He can be reached at his office (for appointments etc.) via phone at (408) 249-6760.

NPI number for Brian Karvelas is 1073657698 and his current mailing address is 902 Newhall St, San Jose, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073657698.

Contact Information

	Brian Karvelas, MD
	902 Newhall St, San Jose, CA 95126-1032
	(408) 249-6760
	(408) 249-6764

Physician's Profile

Full Name	Brian Karvelas
Gender	Male
Speciality	Pain Medicine - Pain Medicine
Location	902 Newhall St, San Jose, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073657698
Provider Enumeration Date: 02/16/2007
Last Update Date: 10/19/2016

Medical Identifiers

Medical identifiers for Brian Karvelas such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073657698	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	A063301 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian Karvelas is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Brian Karvelas, MD 902 Newhall St, San Jose, CA 95126-1032 Ph: (408) 249-6760	Brian Karvelas, MD 902 Newhall St, San Jose, CA 95126-1032 Ph: (408) 249-6760

News Archive

Significant proportion of men with ED exhibit early signs of CAD: Review

International experts are calling for all men experiencing impotence to undergo thorough medical assessments, after an extensive review showed that a significant proportion of men with erectile dysfunction exhibit early signs of coronary artery disease.

Head, neck cancer patients receiving radiation complied with SPP likely to suffer side effects

A study from UCLA's Jonsson Comprehensive Cancer Center (JCCC) has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to suffer unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises called a swallow preservation protocol (SPP) during therapy.

Genetic factors in smoking also increase risk of chronic bronchitis

Smoking is a known risk factor for respiratory diseases like chronic bronchitis, but genes also play a significant role in its development, according to researchers in Sweden, who studied more than 40,000 Swedish twins to determine the extent to which behavior, environment and genes each play a role ion the development of chronic bronchitis.

Genentech, Biogen announce FDA approval of Rituxan to treat follicular lymphoma

Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.

Brian Karvelas, MD - Pain Medicine in San Jose, CA